Emma has worked closely with various medspa professionals
et al., Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA, The Lancet, 2023
No one should take it without medical supervision and a clear clinical reason
Intravenous (IV) administration of glutathione has emerged as a method to improve its bioavailability and therapeutic effects, as there is an increasing interest in wellness and preventive medicine
The peptides administration has been linked to the release of serotonin in brain regions associated with mood and motor control, suggesting a bidirectional communication pathway between the gut and the brain
What this means for you The regulatory uncertainty means that any compounding pharmacy, not just Boothwyn, could face supply disruptions, formula changes, or operational restrictions